Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies
Authors:
Open Access
- 1 April 2024
- journal article
- research article
- Published by SAGE Publications in Health Security
- Vol. 22 (2) , 85-92
Abstract
The surveillance and identification of emerging, reemerging, and unknown infectious disease pathogens is essential to national public health preparedness and relies on fluidity, coordination, and interconnectivity between public and private pathogen surveillance systems and networks. Developing a national sentinel surveillance network with existing resources and infrastructure could increase efficiency, accelerate the identification of emerging public health threats, and support coordinated intervention strategies that reduce morbidity and mortality. However, implementing and sustaining programs to detect emerging and reemerging pathogens in humans using advanced molecular methods, such as metagenomic sequencing, requires making large investments in testing equipment and developing networks of clinicians, laboratory scientists, and bioinformaticians. In this study, we sought to gain an understanding of how federal government agencies currently support such pathogen agnostic testing of human specimens in the United States. We conducted a landscape analysis of federal agency websites for publicly accessible information on the availability and type of pathogen agnostic testing and details on flow of clinical specimens and data. The website analysis was supplemented by an expert review of results with representatives from the federal agencies. Operating divisions within the US Department of Health and Human Services and the US Department of Veterans Affairs have developed and sustained extensive clinical and research networks to obtain patient specimens and perform metagenomic sequencing. Metagenomic facilities supported by US agencies were not equally geographically distributed across the United States. Although many entities have work dedicated to metagenomics and/or support emerging infectious disease surveillance specimen collection, there was minimal formal collaboration across agencies.Keywords
This publication has 24 references indexed in Scilit:
- Toward a global virus genomic surveillance networkCell Host & Microbe, 2023
- The Lancet Commission on lessons for the future from the COVID-19 pandemicThe Lancet, 2022
- COVID-19 Response Among US Hospitals with Emerging Special Pathogen ProgramsHealth Security, 2022
- Ten recommendations for supporting open pathogen genomic analysis in public healthNature Medicine, 2020
- Thinking Globally, Acting Locally — The U.S. Response to Covid-19New England Journal of Medicine, 2020
- Pathogen Genomics in Public HealthNew England Journal of Medicine, 2019
- Clinical Metagenomic Sequencing for Diagnosis of Meningitis and EncephalitisNew England Journal of Medicine, 2019
- Identification of Prosthetic Joint Infection Pathogens Using a Shotgun Metagenomics ApproachClinical Infectious Diseases, 2018
- Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious DiseasesClinical Infectious Diseases, 2017
- Identifying personal microbiomes using metagenomic codesProceedings of the National Academy of Sciences of the United States of America, 2015